title: Calpain-10 Activity Underlies Angiotensin II-Induced Aldosterone Production in an Adrenal Glomerulosa Cell Model.
abstract: Aldosterone is a steroid hormone important in the regulation of blood pressure. Aberrant production of aldosterone results in the development and progression of diseases including hypertension and congestive heart failure; therefore, a complete understanding of aldosterone production is important for developing more effective treatments. Angiotensin II (AngII) regulates steroidogenesis, in part through its ability to increase intracellular calcium levels. Calcium can activate calpains, proteases classified as typical or atypical based on the presence or absence of penta-EF-hands, which are involved in various cellular responses. We hypothesized that calpain, in particular calpain-10, is activated by AngII in adrenal glomerulosa cells and underlies aldosterone production. Our studies showed that pan-calpain inhibitors reduced AngII-induced aldosterone production in 2 adrenal glomerulosa cell models, primary bovine zona glomerulosa and human adrenocortical carcinoma (HAC15) cells, as well as CYP11B2 expression in the HAC15 cells. Although AngII induced calpain activation in these cells, typical calpain inhibitors had no effect on AngII-elicited aldosterone production, suggesting a lack of involvement of classical calpains in this process. However, an inhibitor of the atypical calpain, calpain-10, decreased AngII-induced aldosterone production. Consistent with this result, small interfering RNA (siRNA)-mediated knockdown of calpain-10 inhibited aldosterone production and CYP11B2 expression, whereas adenovirus-mediated overexpression of calpain-10 resulted in increased AngII-induced aldosterone production. Our results indicate that AngII-induced activation of calpain-10 in glomerulosa cells underlies aldosterone production and identify calpain-10 or its downstream pathways as potential targets for the development of drug therapies for the treatment of hypertension.
authors.affiliation: Charlie Norwood Veterans Administration Medical Center (W.B.B.), Augusta, Georgia 30904; Department of Physiology (M.S., W.B.B.) and Section of Dermatology (W.B.B.), Department of Medicine, Georgia Regents University, Augusta, Georgia 30912; and Department of Drug Discovery and Biomedical Sciences (R.G.S.), Medical University of South Carolina, and Ralph H. Johnson VA Medical Center (R.G.S.), Charleston, South Carolina 29425.
authors.forename: Mutsa
authors.initials: M
authors.lastname: Seremwe
authors.forename: Rick G
authors.initials: RG
authors.lastname: Schnellmann
authors.forename: Wendy B
authors.initials: WB
authors.lastname: Bollag
mesh_terms: D000450:Aldosterone / Q000378:metabolism*; D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D002154:Calpain / Q000037:antagonists & inhibitors / Q000378:metabolism*; D002417:Cattle; D045744:Cell Line, Tumor; D002478:Cells, Cultured; D004151:Dipeptides / Q000494:pharmacology; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism; D015384:Zona Glomerulosa / Q000378:metabolism*
chemical_list: D004151:Dipeptides; D000804:Angiotensin II; C071482:calpeptin; D000450:Aldosterone; D002154:Calpain; C058076:calpain inhibitor III; D006854:Hydrocortisone
references.citation: Pharmacol Rev. 1994 Dec;46(4):417-47
references.pmid: 7899472
references.citation: Endocrinology. 1991 Jan;128(1):231-41
references.pmid: 1702701
references.citation: J Pharmacol Exp Ther. 1997 Dec;283(3):1177-84
references.pmid: 9399991
references.citation: J Cell Biol. 1998 May 4;141(3):647-62
references.pmid: 9566966
references.citation: Mol Cell Endocrinol. 1999 Aug 20;154(1-2):1-9
references.pmid: 10509794
references.citation: Mol Endocrinol. 2005 Jan;19(1):213-24
references.pmid: 15471947
references.citation: Diabetes Metab Res Rev. 2005 Nov-Dec;21(6):505-14
references.pmid: 16028216
references.citation: Am J Physiol Cell Physiol. 2006 Dec;291(6):C1159-71
references.pmid: 16790502
references.citation: Biochim Biophys Acta. 2007 Jun;1771(6):663-76
references.pmid: 17433772
references.citation: Biochimie. 2008 Feb;90(2):359-68
references.pmid: 17881114
references.citation: J Clin Endocrinol Metab. 2008 Mar;93(3):992-8
references.pmid: 18089694
references.citation: Circ Res. 2008 Mar 28;102(6):720-8
references.pmid: 18258859
references.citation: PLoS One. 2008;3(5):e2231
references.pmid: 18493299
references.citation: Biochimie. 2008 Sep;90(9):1362-71
references.pmid: 18452715
references.citation: J Clin Endocrinol Metab. 2008 Nov;93(11):4542-6
references.pmid: 18713819
references.citation: J Med Chem. 2009 Jan 8;52(1):181-8
references.pmid: 19072163
references.citation: Am J Physiol Renal Physiol. 2009 Mar;296(3):F478-86
references.pmid: 19144693
references.citation: J Biol Chem. 2010 Jul 23;285(30):22986-98
references.pmid: 20460380
references.citation: Circ Res. 2011 Apr 29;108(9):1102-11
references.pmid: 21415394
references.citation: Proc Jpn Acad Ser B Phys Biol Sci. 2011;87(6):287-327
references.pmid: 21670566
references.citation: Mol Cell Endocrinol. 2012 Mar 24;350(2):151-62
references.pmid: 21839803
references.citation: Mol Cell Endocrinol. 2012 Mar 31;351(1):58-65
references.pmid: 21924324
references.citation: Horm Metab Res. 2012 Mar;44(3):245-50
references.pmid: 22266826
references.citation: ACS Chem Biol. 2012 Aug 17;7(8):1410-9
references.pmid: 22612451
references.citation: Cardiovasc Res. 2012 Oct 1;96(1):32-7
references.pmid: 22581845
references.citation: Biochem J. 2012 Nov 1;447(3):335-51
references.pmid: 23035980
references.citation: Mol Cell Endocrinol. 2001 May 25;177(1-2):61-70
references.pmid: 11377821
references.citation: Physiol Rev. 2003 Jul;83(3):731-801
references.pmid: 12843408
references.citation: Neurosci Res. 2003 Sep;47(1):131-5
references.pmid: 12941454
references.citation: Physiol Rev. 2004 Apr;84(2):489-539
references.pmid: 15044681
references.citation: J Biol Chem. 2004 May 14;279(20):20775-85
references.pmid: 14988399
references.citation: Mol Cell Endocrinol. 2004 Mar 31;217(1-2):53-8
references.pmid: 15134801
references.citation: Mol Cell Endocrinol. 2004 Mar 31;217(1-2):67-74
references.pmid: 15134803
references.citation: Biochem J. 2004 Sep 15;382(Pt 3):1015-23
references.pmid: 15239673
references.citation: Science. 1987 Apr 10;236(4798):188-90
references.pmid: 3563495
references.citation: Endocr Rev. 1989 Nov;10(4):496-518
references.pmid: 2558878
references.citation: Mol Endocrinol. 1989 Dec;3(12):1944-52
references.pmid: 2628731
references.citation: Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6687-92
references.pmid: 8692879